Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial.

Journal: The lancet. HIV

Publication Year: 

Authors & Co-authors:  Stranix-Chibanda Lynda L Hamilton Erica L EL Ngo Julie J Jiao Yuqing Y Hanscom Brett B Choudhury Rahul Paul RP Agyei Yaw Y Piwowar-Manning Estelle E Marzinke Mark M Delany-Moretlwe Sinead S

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.

Journal: Lancet (London, England)

Publication Year: 2022

Authors & Co-authors:  Delany-Moretlwe Hughes Bock Ouma Hunidzarira Kalonji Kayange Makhema Mandima Mathew